{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:43:00Z","timestamp":1792723380021,"version":"4.5.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1001\/jamapediatrics.2020.0007","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T11:31:03Z","timestamp":1584358263000},"page":"543","source":"Crossref","is-referenced-by-count":76,"title":["Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children"],"prefix":"10.1001","volume":"174","author":[{"given":"Yun-Han","family":"Wang","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Wintzell","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pediatrics, \u00d6rebro University Hospital, \u00d6rebro, Sweden"},{"name":"School of Medicine, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom"},{"name":"Celiac Disease Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"poi200002r1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MPG.0000000000001401","article-title":"ESPGHAN-NASPGHAN guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal fistula.","volume":"63","author":"Krishnan","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"poi200002r2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.","volume":"66","author":"Rosen","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"19","key":"poi200002r3","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents-united states, 1999-2014.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"poi200002r4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/archdischild-2017-314026","article-title":"Toxicity of long-term use of proton pump inhibitors in children.","volume":"103","author":"De Bruyne","year":"2018","journal-title":"Arch Dis Child"},{"issue":"2","key":"poi200002r5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.","volume":"15","author":"Ward","year":"2013","journal-title":"Paediatr Drugs"},{"issue":"4","key":"poi200002r6","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/BPO.0000000000000595","article-title":"Epidemiology of pediatric fractures presenting to emergency departments in the United States.","volume":"36","author":"Naranje","year":"2016","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"poi200002r7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00198-005-2009-y","article-title":"Children who experience their first fracture at a young age have high rates of fracture.","volume":"17","author":"Yeh","year":"2006","journal-title":"Osteoporos Int"},{"issue":"9","key":"poi200002r8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16091571","article-title":"Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved.","volume":"16","author":"Thong","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"poi200002r9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","article-title":"Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis.","volume":"218","author":"Liu","year":"2019","journal-title":"Life Sci"},{"key":"poi200002r10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpeds.2018.11.017","article-title":"Prematurity does not increase early childhood fracture risk.","volume":"207","author":"Wagner","year":"2019","journal-title":"J Pediatr"},{"issue":"1","key":"poi200002r11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2625","article-title":"Early acid suppression therapy exposure and fracture in young children.","volume":"144","author":"Malchodi","year":"2019","journal-title":"Pediatrics"},{"issue":"10","key":"poi200002r12","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","article-title":"Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.","volume":"26","author":"Freedberg","year":"2015","journal-title":"Osteoporos Int"},{"key":"poi200002r13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"1","key":"poi200002r14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/bimj.v51:1","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations.","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"issue":"11","key":"poi200002r15","first-page":"2439","article-title":"Extension of disease risk score-based confounding adjustments for multiple outcomes of interest: an empirical evaluation.","volume":"187","author":"Desai","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"1","key":"poi200002r16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12876-018-0780-4","article-title":"Relationship between Helicobacter pylori infection and bone mineral density: a retrospective cross-sectional study.","volume":"18","author":"Pan","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"poi200002r17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"5","key":"poi200002r18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"poi200002r19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","article-title":"Medications associated with fracture risk in patients with rheumatoid arthritis.","volume":"78","author":"Ozen","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"poi200002r20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"poi200002r21","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13339","article-title":"Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.","volume":"73","author":"Fedida","year":"2019","journal-title":"Int J Clin Pract"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2762641\/jamapediatrics_wang_2020_oi_200002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T11:03:41Z","timestamp":1591009421000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2762641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2020.0007","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}